Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EML4 antisense RNA 1 (EML4-AS1) is a long non-coding RNA gene located on chromosome 2, transcribed antisense to the EML4 gene. Unlike the protein-coding gene EML4 or the oncogenic fusion protein EML4-ALK, EML4-AS1 does not encode a protein but may have regulatory functions affecting its sense gene or related cellular pathways. There is currently limited experimental or clinical data available regarding its precise role in physiology or disease, and it is not currently established as a direct therapeutic target or clinical biomarker. Note: EML4-AS1 should not be confused with EML4 (the microtubule-associated protein) or EML4-ALK (the oncogenic fusion protein found in certain lung cancers).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EML4 antisense RNA 1 (EML4-AS1).